Showing results (771-780 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|July 21, 2017
Mismatch repair deficient metastatic colon cancer and urothelial cancer: A case report of sequential immune checkpoint therapyPooja Ghatalia, Rajeswari Nagarathinam, Harry Cooper, et al.Cancer Biology & Therapy|November 14, 2017
A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomachLaura Caggiari, Gianmaria Miolo, Vincenzo Canzonieri, et al.Cancer Biology & Therapy|September 9, 2017
MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC)Émilie A Graham, Jean-François Mallet, Majed Jambi, et al.Cancer Biology & Therapy|September 9, 2017
Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancerAvital Lev, Safoora Deihimi, Elena Shagisultanova, et al.Cancer Biology & Therapy|September 9, 2017
The roles of vasohibin and its family members: Beyond angiogenesis modulatorsHua Du, Jing Zhao, Ling Hai, et al.Cancer Biology & Therapy|September 8, 2017
Effective treatment of aggressive fibromatosis with celecoxib guided by genetic testingShanshan Yang, Xufu Wang, Haiping Jiang, et al.Cancer Biology & Therapy|December 10, 2015
Transketolase-like protein 1 expression predicts poor prognosis in colorectal cancerKaisa Ahopelto, Camilla Böckelman, Jaana Hagström, et al.Cancer Biology & Therapy|March 9, 2016
A specific aptamer-cell penetrating peptides complex delivered siRNA efficiently and suppressed prostate tumor growth in vivoYanjun Diao, Jiayun Liu, Yueyun Ma, et al.Cancer Biology & Therapy|December 10, 2015
Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature?Sara Di Lorenzo, Daniele Fanale, Bartolo Corradino, et al.Cancer Biology & Therapy|November 11, 2015
Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?Vincenzo Graziano, Maria Teresa Scognamiglio, Marinella Zilli, et al.Pageof 387